Board Business:
Zhang Promoted to Associate Professor with Tenure, Dammeyer
and Insley Join Board
A faculty promotion and the appointment of two new board
members were approved at a recent meeting of The Scripps Research
Institute (TSRI) Board of Trustees.
Zhang Receives Tenure
Investigator Dong-Er Zhang is now associate professor with
tenure in the Department of Molecular and Experimental Medicine.
Zhang (B.S., Peking University; Ph.D., University of Houston)
came to TSRI in 1999. Zhang's major research interests center
around the transcriptional regulation in blood cell differentiation
and the function of a ubiquitin-like modifier ISG15 in signal
transduction.
Other faculty members recently receiving promotions include:
• Francisco J. Asturias, promoted to associate professor
in the Department of Cell Biology;
• David Alexander Calderwood, promoted to assistant professor
of the Department of Cell Biology;
• Miguel A. del Pozo, promoted to assistant professor
in the Department of Immunology;
• Philippe Gallay, promoted to associate professor in
the Department of Immunology;
• Richard Klemke, promoted to associate professor in
the Department of Immunology;
• Erica Ollmann Saphire, promoted to assistant professor
in the Department of Immunology;
• Masahiro Aoki, promoted to assistant professor in the
Department of Molecular and Experimental Medicine, Division
of Oncovirology;
• Andrew Gale, promoted to assistant professor in the
Department of Molecular and Experimental Medicine, Division
of Experimental Hemostasis and Thrombosis.
Dammeyer and Insley Join Board
The board welcomed new trustees Rod Dammeyer and Thomas
Insley.
Dammeyer is president of CAC, LLC, a private company offering
capital investment and management advisory services.
His previous positions include: managing partner of Equity
Group Corporate Investments (1995-2000), CEO of Itel Corporation
(1985-1995), senior vice president and chief financial officer
of Household International, Inc. (1983-85), executive vice
president and chief financial officer of Northwest Industries
(1979-83), and member, then partner, of Arthur Andersen &
Co. (1962-79).
A graduate of Kent State University, Dammeyer is a member
of the boards of directors of GATX Corporation, Stericycle,
Inc., TeleTech Holdings, Inc., and TheraSense, Inc., in addition
to several private companies. He is also a trustee of Van
Kampen Funds (investment funds of Morgan Stanley), and the
University of Chicago Hospitals & Health System.
Insley is vice president and chief financial officer of
SkinMedica, Inc., a privately held specialty pharmaceutical
company.
From 2002 to 2003, Insley was chief financial officer, corporate
secretary, and member of the Board of Directors of Molecular
Imaging Corporation, a publicly traded company that provides
Positron Emission Tomography services to hospitals and medical
clinics. Prior to this position, Insley spent 29 years with
PricewaterhouseCoopers, where he had major client responsibilities
in the wireless communications, software, and life sciences
industries.
Insley, who has a B.A. in accounting from Franklin and Marshall
College, is currently on the board of directors of NexPrise,
and is active in the American Institute of Certified Public
Accountants and California Society of CPAs, BIOCOM San Diego,
San Diego Regional Economic Development Corporation, The Globe
Theatres, and UC San Diego Foundation.
Board Thanks Safer
In addition, the board passed a resolution expressing its
gratitude to successful entrepreneur and world-renowned sculptor
John Safer, who is retiring from the board after seven years
of service. The board extended "its deepest appreciation and
gratitude to John Safer for his wise stewardship, outstanding
leadership, and unstinting service to the institute, its mission,
and its achievements."
|
Dong-Er Zhang is associate professor in the Department
of Molecular and Experimental Medicine, Division of Oncovirology.
Photo by Michael Balderas.
TSRI trustee Rod Dammeyer is president
of CAC, LLC, a private company offering capital investment
and management advisory services. Photo copyright:
Stewart Cohen Pictures.
TSRI trustee Thomas Insley is vice president
and chief financial officer of SkinMedica, Inc., a privately
held specialty pharmaceutical company. Photo
by Mark Brlej.
|
